
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Serendipity Partners is a venture capital firm based in Oslo, Norway, established to invest in the healthcare sector across Europe, with a particular emphasis on the Nordic region. Founded with the mission to partner with companies that prioritize sustainable growth and strategic vision, the firm has successfully raised NOK 2.2 billion (approximately $220 million) across two funds. The team at Serendipity Partners boasts over three decades of experience in supporting the growth of healthcare companies, positioning them as knowledgeable investors in this specialized field.
Currently, Serendipity Partners manages a portfolio of 10 companies, reflecting their focused investment strategy. The firm operates from its headquarters in Oslo and has built a reputation for its commitment to long-term partnerships with both public and family business owners. Notable milestones include their successful fundraising efforts and the establishment of a diverse portfolio that underscores their expertise in the healthcare sector.
Serendipity Partners concentrates its investments in the healthcare sector, specifically targeting mature, cash flow-positive businesses. The firm seeks to establish long-term partnerships with both public and family business owners, emphasizing a collaborative approach that avoids excessive leverage in their investments. Their investment strategy includes active ownership, which aligns management incentives with those of investors, ensuring a shared vision for growth.
In addition to their focus on sustainable growth, Serendipity Partners looks for businesses with a clear and analyzable value proposition. This approach allows them to identify companies that not only demonstrate financial stability but also possess the potential for significant long-term impact in the healthcare industry. Their geographic focus remains primarily within Europe, particularly in the Nordic region, where they leverage their local expertise and connections.
Serendipity Partners has built a notable portfolio of 10 companies within the healthcare sector, showcasing their investment strategy and focus on mature businesses. Key portfolio companies include:
This diverse portfolio reflects Serendipity Partners' commitment to investing in companies that are not only financially viable but also contribute positively to the healthcare landscape.
Egil Bodd: Managing Partner with extensive experience in healthcare investments and strategic growth initiatives.
Michael Bodd: Partner specializing in operational support and business development within the healthcare sector.
Wenche Rolfsen: Partner with a focus on investment strategy and portfolio management.
Christopher Tangen: Partner known for his expertise in healthcare market dynamics and investment analysis.
Lars Mariero: Partner with a background in healthcare entrepreneurship and innovation.
Joachim Andersen: Investment Director with a strong track record in deal sourcing and execution.
Katherine Wang: Investment Manager focused on due diligence and portfolio support.
Henrik August Tran-Thoresen: CFO responsible for financial oversight and fund management.
To pitch to Serendipity Partners, founders should send an email to post@serpar.no. A comprehensive pitch deck is essential, detailing the business model, market analysis, and financial projections. The firm values clarity and thoroughness in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
As of October 2023, Serendipity Partners continues to expand its portfolio in the healthcare sector, focusing on mature companies with sustainable growth potential. Recent investments include notable companies in the Nordic region, reflecting their commitment to supporting innovative healthcare solutions.
The firm has also been active in discussions regarding future fundraising efforts, aiming to further enhance their capital base for upcoming investment opportunities.
What are Serendipity Partners' investment criteria?
Serendipity Partners invests in mature, cash flow-positive healthcare companies. They prioritize long-term partnerships with public and family business owners and prefer to avoid excessive leverage in their investments.
How can I apply or pitch to Serendipity Partners?
Founders can reach out via email at post@serpar.no to discuss potential investment opportunities. A detailed pitch deck outlining the business model, market potential, and financial projections is recommended.
What makes Serendipity Partners different from other investors?
The firm emphasizes active ownership and aligns management incentives with those of investors, ensuring a collaborative approach to growth. Their focus on sustainable growth in the healthcare sector sets them apart.
What is the geographic scope of Serendipity Partners' investments?
Serendipity Partners primarily invests in the Nordic region and broader European healthcare market, leveraging their local expertise and connections.
What is the typical check size for investments?
While specific check sizes are not disclosed, Serendipity Partners focuses on mature companies, indicating a preference for substantial investments that align with their strategy.
What kind of post-investment involvement can founders expect?
Serendipity Partners engages in active ownership, which includes working closely with portfolio companies to align management incentives and support strategic growth initiatives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.